Author: Aaron Atkinson
Emerging regulations – Prescription drugs and oral fluid
SAMHSA recently announced that it has accepted the recommendations of its Drug Testing Advisory Board (DTAB).
The benefits of Oral-Eze
Feedback from Oral-Eze users is that it helps to resolve a number of the concerns encountered using other oral fluid drug testing systems.
National survey shows a rise in illicit drug use
The use of illicit drugs among Americans increased between 2008 and 2010 according to a national survey conducted by SAMHSA.
DATIA publishes “data-driven insights” article
The Drug and Alcohol Testing Industry Association (DATIA) publishes a quarterly magazine.
Methamphetamine data published in new Drug Testing Index
The study includes its first state-by-state analysis of methamphetamine positives.
The health crises of chronic pain and prescription drug misuse
The Medical Laboratory Observer recently published an article written by Quest Diagnostics Jon R. Cohen, MD, Senior Vice President and Chief Medical Officer.
Quest Diagnostics introduces Oral-Eze
Quest Diagnostics is pleased to announce our innovative oral fluid collection system, simplifying the oral fluid samples for workplace drug testing.
Obama cracks down on medical marijuana
The Justice Department is warning that medical marijuana shops aren't immune from prosecution.
DEA: Marijuana still classified as highly dangerous drug
The Drug Enforcement Administration (DEA) recently announced that medical marijuana should continue to be classified as a Schedule I drug."
2011 National drug control strategy
This week, the National Drug Control Policy Director Gil Kerlikowske released the 2011 National Drug Control Strategy.
